A large, longitudinal genome-wide association study has identified novel genetic variants associated with resilience to Alzheimer’s disease (AD).
The study was based on nearly 16,000 patients, pooled from 4 longitudinal cohort studies of aging and AD (the ACT, ADNI, NACC, and ROSMAP studies).